Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: HIV Med. 2010 Aug 31;12(4):219–227. doi: 10.1111/j.1468-1293.2010.00875.x

Table 2.

ESPRIT - First Bacterial Pneumonia Event by Proximal CD4

IL-2
Control
CD4 Pt yrs Events Ratea) Pt yrs Events Ratea) HRb) p-val
< 100 64 2 3.13 60 1 1.66 1.93 .59
100 - 199 194 2 1.03 212 3 1.41 0.77 .77
200 - 349 1117 12 1.07 1879 21 1.12 1.01 .97
350 - 499 2540 23 0.91 4011 24 0.60 1.55 .13
500 - 699 3639 22 0.60 4253 23 0.54 1.11 .73
≥ 700 6281 32 0.51 3131 14 0.45 1.10 .77
Total 13836 93 0.67 13547 86 0.63

HR (p) for 100 cells c) 0.89 (.001) 0.90 (.05) Int.d)
CD4 Coeff (SE) −0.0012 (0.0004) −0.0010 (0.0005) .71
Log10 CD4 Coeff (SE) −1.537 (0.375) −1.194 (0.461) .62
a)

Rate per 100 person yrs of follow-up in that category. Events are attributed to last CD4 recorded prior to the event. Assumes patient stays in that category until a CD4 is measured in an alternate category, or until the censoring date. Uses interim and visit-associated lab values.

b)

Hazard ratio (IL-2 vs. control) and p-value from Cox model with treatment group and time-updated CD4 strata.

c)

HR and p-value for time-updated CD4 (100 cells) from Cox model, run separately by treatment group.

d)

Interaction p-value is for treatment group by time-updated CD4 in a model containing time-updated CD4, treatment group, and an interaction term.